Publication date: 2018-09-16 18:06
Healthline Media, Inc. is based in and operates this site from the United States. Any data you provide will be primarily stored and processed in the United States, pursuant to the laws of the United States, which may provide lesser privacy protections than European Economic Area countries.
Family history: If a person''s mother, father, brother, or sister has had liver cancer, the person has a higher risk than others of developing the cancer themselves.
According to the American Cancer Society’s most recent estimates, there are about 97,775 new cases of primary liver cancer and bile duct cancer in the United States and about 85,755 deaths from these cancers.
Ablation therapy : This is a procedure that can kill cancer cells in the liver without any surgery. The doctor can kill cancer cells using heat, laser, or by injecting a special alcohol or acid directly into the cancer. This technique also may be used in palliative care when the cancer is unresectable.
Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). The way the chemotherapy is given depends on the type and stage of the cancer being treated.
Incidence rates of hepatocellular cancer are rising in the United States due to increasing prevalence of cirrhosis caused by chronic hepatitis C and steatohepatitis (nonalcoholic fatty liver disease).
The American Joint Committee on Cancer (AJCC) TNM system is the most widely accepted method for liver cancer staging. This system bases the staging criteria on the evaluation of three primary factors:
Hepatitis C : This is an RNA virus, causing millions of infections over the past few decades by contaminated needles or blood products before a screening test was developed. This infection is responsible now for about three-quarters of all hepatomas in Japan and Europe. After infection, there is a lifetime risk of 5% of developing hepatoma, at an average time of 78 years after infection.
In some cases of liver cancer, your medical team may talk to you about palliative care. Palliative care aims to improve your quality of life by alleviating symptoms of cancer.